Profil
Christopher Gagliardi has held multiple current jobs.
He is currently the Director at I2o Therapeutics, Inc. Additionally, he holds the position of Principal at Sanofi Ventures since 2017.
He is also a Board member at Minervax ApS since 2020.
In terms of education, Dr. Gagliardi completed his undergraduate degree at Roger Williams University and obtained a doctorate degree from The University of North Carolina at Chapel Hill.
Postes actifs de Christopher Gagliardi
| Sociétés | Poste | Début |
|---|---|---|
I2o Therapeutics, Inc.
I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops injection pills for biological therapies | Directeur/Membre du Conseil | - |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Private Equity Investor | 01/11/2017 |
Minervax ApS
Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults | Directeur/Membre du Conseil | 01/12/2020 |
Formation de Christopher Gagliardi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Roger Williams University
Roger Williams University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi Ventures
Sanofi Ventures Investment ManagersFinance Sanofi Ventures nvests in companies located in the United States. The firm targets companies operating in the fields of biotech and digital health. t provides financing for seed and early stage capital requirements. It acts as lead investor and also takes a seat on board of directors. | Finance |
Minervax ApS
Minervax ApS Pharmaceuticals: MajorHealth Technology Develops prophylactic vaccines for pregnant women and older adults | Health Technology |
I2o Therapeutics, Inc.
I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops injection pills for biological therapies | Health Technology |
















